-
公开(公告)号:US20090123463A1
公开(公告)日:2009-05-14
申请号:US10579529
申请日:2004-11-17
CPC分类号: C07K14/475 , A61K38/00
摘要: The C-terminal domain of focal adhesion kinase (FAK-CD) was isolated using a Baculoviral system. Using phage display techniques, a phage encoding a 12 amino-acid peptide (peptide 35) and AV3 that binds to FAK-CD were identified. The peptides were also conjugated to TAT-FITC to produce a fluorescently labeled chimeric molecule capable of penetrating cell membranes. Contacting various breast cancer cell lines with these molecule caused detachment, rounding, apoptosis and cell death. These effects were not observed in normal (non-cancerous) breast cells.
摘要翻译: 使用杆状病毒系统分离局灶粘连激酶(FAK-CD)的C-末端结构域。 使用噬菌体展示技术,鉴定了编码结合FAK-CD的12个氨基酸肽(肽35)和AV3的噬菌体。 肽也与TAT-FITC偶联以产生能够穿透细胞膜的荧光标记的嵌合分子。 与这些分子接触各种乳腺癌细胞系导致分离,四舍五入,细胞凋亡和细胞死亡。 在正常(非癌)乳腺细胞中没有观察到这些作用。
-
2.
公开(公告)号:US08404669B2
公开(公告)日:2013-03-26
申请号:US12283826
申请日:2008-09-15
CPC分类号: A61K31/17 , A61K31/4184 , A61K31/4375 , A61K31/44 , A61K31/473 , A61K31/529 , A61K31/5415 , A61K45/06 , A61K2300/00
摘要: The invention relates to protein binding inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating a variety of diseases and disorders, including cell proliferative disorders, especially cancer.
摘要翻译: 本发明涉及蛋白质结合抑制剂化合物及其鉴定和使用方法。 本发明还涉及用于治疗多种疾病和病症的药物组合物和方法,包括细胞增殖性疾病,特别是癌症。
-
公开(公告)号:US20110065664A1
公开(公告)日:2011-03-17
申请号:US12867997
申请日:2009-02-18
IPC分类号: A61K31/7068 , A61K31/136 , A61P35/00
CPC分类号: C07D487/18 , A61K31/136 , A61K31/495 , A61K31/55 , A61K31/7068 , A61K45/06 , C07C211/50 , C07D513/18 , A61K2300/00
摘要: The invention relates to phosphorylation inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating cell proliferative disorders, especially cancer.
摘要翻译: 本发明涉及磷酸化抑制剂化合物及其鉴定和使用方法。 本发明还涉及用于治疗细胞增殖性疾病,特别是癌症的药物组合物和方法。
-
公开(公告)号:US08003613B2
公开(公告)日:2011-08-23
申请号:US10579529
申请日:2004-11-17
CPC分类号: C07K14/475 , A61K38/00
摘要: The C-terminal domain of focal adhesion kinase (FAK-CD) was isolated using a Baculoviral system. Using phage display techniques, a phage encoding a 12 amino-acid peptide (peptide 35) and AV3 that binds to FAK-CD were identified. The peptides were also conjugated to TAT-FITC to produce a fluorescently labeled chimeric molecule capable of penetrating cell membranes. Contacting various breast cancer cell lines with these molecule caused detachment, rounding, apoptosis and cell death. These effects were not observed in normal (non-cancerous) breast cells.
摘要翻译: 使用杆状病毒系统分离局灶粘连激酶(FAK-CD)的C-末端结构域。 使用噬菌体展示技术,鉴定了编码结合FAK-CD的12个氨基酸肽(肽35)和AV3的噬菌体。 肽也与TAT-FITC偶联以产生能够穿透细胞膜的荧光标记的嵌合分子。 与这些分子接触各种乳腺癌细胞系导致分离,四舍五入,细胞凋亡和细胞死亡。 在正常(非癌)乳腺细胞中没有观察到这些作用。
-
公开(公告)号:US20090239850A1
公开(公告)日:2009-09-24
申请号:US12283826
申请日:2008-09-15
CPC分类号: A61K31/17 , A61K31/4184 , A61K31/4375 , A61K31/44 , A61K31/473 , A61K31/529 , A61K31/5415 , A61K45/06 , A61K2300/00
摘要: The invention relates to protein binding inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating a variety of diseases and disorders, including cell proliferative disorders, especially cancer.
摘要翻译: 本发明涉及蛋白质结合抑制剂化合物及其鉴定和使用方法。 本发明还涉及用于治疗多种疾病和病症的药物组合物和方法,包括细胞增殖性疾病,特别是癌症。
-
公开(公告)号:US08314150B2
公开(公告)日:2012-11-20
申请号:US12867997
申请日:2009-02-18
IPC分类号: A01N33/02 , A61K31/135
CPC分类号: C07D487/18 , A61K31/136 , A61K31/495 , A61K31/55 , A61K31/7068 , A61K45/06 , C07C211/50 , C07D513/18 , A61K2300/00
摘要: The invention relates to phosphorylation inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating cell proliferative disorders, especially cancer.
摘要翻译: 本发明涉及磷酸化抑制剂化合物及其鉴定和使用方法。 本发明还涉及用于治疗细胞增殖性疾病,特别是癌症的药物组合物和方法。
-
公开(公告)号:US20120164141A1
公开(公告)日:2012-06-28
申请号:US13214916
申请日:2011-08-22
IPC分类号: A61K38/10 , C12N5/02 , C12N15/63 , A61P35/00 , A61K39/395
CPC分类号: C07K14/475 , A61K38/00
摘要: The C-terminal domain of focal adhesion kinase (FAK-CD) was isolated using a Baculoviral system. Using phage display techniques, a phage encoding a 12 amino-acid peptide (peptide 35) and AV3 that binds to FAK-CD were identified. The peptides were also conjugated to TAT-FITC to produce a fluorescently labeled chimeric molecule capable of penetrating cell membranes. Contacting various breast cancer cell lines with these molecule caused detachment, rounding, apoptosis and cell death. These effects were not observed in normal (non-cancerous) breast cells.
摘要翻译: 使用杆状病毒系统分离局灶粘连激酶(FAK-CD)的C-末端结构域。 使用噬菌体展示技术,鉴定了编码结合FAK-CD的12个氨基酸肽(肽35)和AV3的噬菌体。 肽也与TAT-FITC偶联以产生能够穿透细胞膜的荧光标记的嵌合分子。 与这些分子接触各种乳腺癌细胞系导致分离,四舍五入,细胞凋亡和细胞死亡。 在正常(非癌)乳腺细胞中没有观察到这些作用。
-
公开(公告)号:US20120100227A1
公开(公告)日:2012-04-26
申请号:US13255053
申请日:2010-03-04
IPC分类号: A61K33/24 , A61K31/513 , A61K31/5377 , G06G7/75 , A61K31/704 , A61K31/337 , A61K31/7048 , A61P35/00 , A61K31/53 , A61K31/167
CPC分类号: A61K31/395 , A61K31/40 , A61K31/54 , A61K45/06 , A61K2300/00
摘要: The invention relates to protein binding inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating a variety of diseases and disorders, including cell proliferative disorders, especially cancer.
摘要翻译: 本发明涉及蛋白质结合抑制剂化合物及其鉴定和使用方法。 本发明还涉及用于治疗多种疾病和病症的药物组合物和方法,包括细胞增殖性疾病,特别是癌症。
-
-
-
-
-
-
-